Ativan: Clinical Trials

6 trials of Ativan, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 active not recruiting, 1 terminated, 1 unknown. 6 Phase 3, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 36Completed 3, Active not recruiting 1, Terminated 1, Unknown 1
Phase 23Completed 2, Active not recruiting 1

Follow Ativan: new trials by email Literature Review of Ativan trials Research Report on Ativan

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intranasal Dexmedetomidine vs. Standard of Care for Emergency Department (ED) Procedural Sedation in the Older Adult
Dexmedetomidine, Lorazepam, Haloperidol - Altered Mental Status
Phase 3UnknownState University of New York - Upstate Medical University602024-06-012024-04-22
Haloperidol and Lorazepam in Controlling Symptoms of Persistent Agitated Delirium in Patients With Advanced Cancer Undergoing Palliative Care
Haloperidol, Lorazepam, Placebo - Delirium, Locally Advanced Malignant Neoplasm
Phase 2 / Phase 3Active not recruitingM.D. Anderson Cancer Center1102019-07-172026-06-15
Clobazam Use in Epilepsia Partialis Continua - Pilot Study
Clobazam, Clonazepam, Lorazepam - Epilepsia Partialis Continua, Kojewnikov's Epilepsy
Phase 3TerminatedThe Cooper Health System72014-07-012018-05-09
Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications
Intramuscular route of active treatment, Intravenous route of active treatment - Status Epilepticus
Phase 3CompletedRobert Silbergleit10232009-06-012016-06-17
Efficacy and Safety Study Comparing Lorazepam and Diazepam for Children in the Emergency Department With Seizures (Status 2)
lorazepam or diazepam - Status Epilepticus
Phase 2 / Phase 3CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)2592008-02-012012-12-18
Lorazepam Sedation for Critically Ill Children
Lorazepam, Midazolam, Lorazepam CI - Critical Illness
Phase 2 / Phase 3CompletedThe Emmes Company, LLC1792004-09-012023-03-20

Conditions studied

Status Epilepticus (2)  ·  Critical Illness (1)  ·  Delirium (1)  ·  Epilepsia Partialis Continua (1)  ·  Epilepsy (1)  ·  Epilepsy, Partial, Motor (1)  ·  Neoplasm Metastasis (1)  ·  Recurrence (1)  ·  Seizures (1)

Sponsors

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  M.D. Anderson Cancer Center (1)  ·  Robert Silbergleit (1)  ·  State University of New York - Upstate Medical University (1)  ·  The Cooper Health System (1)  ·  The Emmes Company, LLC (1)

Countries

United States (5)  ·  Brazil (1)  ·  Canada (1)

Top investigators

Daniel H Lowenstein, MD (1)  ·  David Hui (1)  ·  James Chamberlain, MD (1)  ·  Jeffrey L Blumer, MD, PhD (1)  ·  Melissa Carran, MD (1)  ·  Robert Silbergleit, MD (1)  ·  Valerie L Durkalski, PhD (1)  ·  William Paolo, MD (1)

Results publications

PMID 21967361, PMID 22144928, PMID 22335736, PMID 22506949, PMID 22950484, PMID 24001080, PMID 24756515, PMID 27993298, PMID 28781452, PMID 32029262, PMID 33692709, PMID 33728561, PMID 34238838, PMID 34546899, PMID 34820831, PMID 35971024, PMID 35987977, PMID 36448276, PMID 40742738

NIH funding

U01NS056975 (1)